Latest news
IBRX Stokes Retail Chatter — Investors See Anktiva Beat Merck’s Keytruda With Approval In EU - StocktwitsStocktwits · Fri, 07 Aug 2026 11:34:22 GMT[MKKGY Q2 2026 Earnings Call] Merck KGaA Hikes Full-Year Profit Target to €6.3 Billion as Bioprocessing and AI Demand Drive Q2 Beat - finance.biggo.comfinance.biggo.com · Thu, 06 Aug 2026 14:56:00 GMTMerck raises 2026 profit guidance, beats quarterly estimates - DevdiscourseDevdiscourse · Thu, 06 Aug 2026 09:59:55 GMTMerck raises 2026 profit guidance, beats quarterly estimates - Euronext Markets: Real-time Stock Market Data | liveEuronext Markets: Real-time Stock Market Data | live · Thu, 06 Aug 2026 09:59:21 GMTMerck Beats Q2 Estimates with $16.6 Billion in Sales as Keytruda and Winrevair Drive Growth - BBN TimesBBN Times · Wed, 05 Aug 2026 19:35:17 GMTMerck & Co., Inc. (NYSE:MRK) Releases Earnings Results, Beats Expectations By $0.13 EPS - MarketBeatMarketBeat · Tue, 04 Aug 2026 16:25:33 GMTMerck posts better-than-expected second-quarter results on Keytruda strength - ReutersReuters · Tue, 04 Aug 2026 15:12:01 GMTMerck Delivers a Clean Earnings Beat on Oncology Strength. Is It Enough to Impress Wall Street? - BitgetBitget · Tue, 04 Aug 2026 11:44:26 GMT